189281-66-1 Usage
Description
METHYL 2,6-DICHLORO-5-FLUORONICOTINATE is a chemical compound that serves as a building block in the pharmaceutical industry for the synthesis of various bioactive molecules. It is a derivative of nicotinic acid, known for its potent insecticidal activities and potential use in the treatment of various diseases. METHYL 2,6-DICHLORO-5-FLUORONICOTINATE is also utilized in the development of agrochemicals and as an intermediate in the production of pharmaceutical compounds, exhibiting promising properties for diverse applications in chemical research and development.
Uses
Used in Pharmaceutical Industry:
METHYL 2,6-DICHLORO-5-FLUORONICOTINATE is used as a building block for the synthesis of various bioactive molecules, contributing to the development of new pharmaceutical compounds.
Used in Agrochemical Development:
METHYL 2,6-DICHLORO-5-FLUORONICOTINATE is used as a component in the development of agrochemicals, leveraging its potent insecticidal activities for pest control in agriculture.
Used in Disease Treatment Research:
METHYL 2,6-DICHLORO-5-FLUORONICOTINATE is used as a subject of study for its potential application in the treatment of various diseases, exploring its therapeutic properties.
Used as an Intermediate in Pharmaceutical Production:
METHYL 2,6-DICHLORO-5-FLUORONICOTINATE is used as an intermediate in the production process of various pharmaceutical compounds, facilitating the synthesis of active ingredients.
Check Digit Verification of cas no
The CAS Registry Mumber 189281-66-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,9,2,8 and 1 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 189281-66:
(8*1)+(7*8)+(6*9)+(5*2)+(4*8)+(3*1)+(2*6)+(1*6)=181
181 % 10 = 1
So 189281-66-1 is a valid CAS Registry Number.
InChI:InChI=1/C7H4Cl2FNO2/c1-13-7(12)3-2-4(10)6(9)11-5(3)8/h2H,1H3
189281-66-1Relevant articles and documents
Nitrogen-containing polycyclic compound as well as preparation method and application thereof
-
Paragraph 0157-0159, (2021/02/10)
The invention discloses a nitrogen-containing polycyclic compound as well as a preparation method and application thereof, and particularly relates to a nitrogen-containing polycyclic compound as shown in a general formula I, or pharmaceutically acceptable salts thereof, or enantiomers, diastereoisomers, tautomers, torsional isomers, solvates, polymorphic substances or prodrugs thereof, as well asa preparation method and pharmaceutical application thereof. The definition of each group is as shown in the specification.
Fused cyanopyridine compound and preparation method and application thereof
-
Paragraph 0143; 0144, (2021/01/11)
The invention discloses a fused cyanopyridine compound shown as a general formula I-1 or I-2, or a pharmaceutically acceptable salt thereof, or an enantiomer, a diastereoisomer, a tautomer, a torsional isomer, a solvate, a polymorphic substance or a prodrug thereof, and a preparation method and a pharmaceutical application of the fused cyanopyridine compound, wherein the definition of each group is shown in the specification.
Novel compounds
-
Paragraph 0076, (2017/09/27)
The present invention relates to novel retinoid-related orphan receptor gamma (RORγ) modulators and their use in the treatment of diseases mediated by RORγ.
